Which is the Preferred Regimen for Non-Severe Clostridioides difficile Infection in Korea, Vancomycin or Metronidazole?

The emergence of hypervirulent Clostridioides difficile strains has decreased the efficacy of metronidazole in the treatment of C. difficile infection (CDI). Therefore, revised guidelines no longer recommend the use of metronidazole as a first-line regimen for CDI and restrict its use for non-severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jieun, Kim, Jinyeong, Kim, Bongyoung, Pai, Hyunjoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259900/
https://www.ncbi.nlm.nih.gov/pubmed/35706079
http://dx.doi.org/10.3947/ic.2022.0027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259900/
https://www.ncbi.nlm.nih.gov/pubmed/35706079
http://dx.doi.org/10.3947/ic.2022.0027

Ejemplares similares